Vimarsana
Biggest News Aggregation in the World

Page 4 - Launch Dynamix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Launch Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Launch Dynamix Today - Breaking & Trending Today

U.S. Nephrologists Report Mixed Reactions to the Approval of GSK's Jesduvroq® (daprodustat) for the Treatment of Anemia in Dialysis Patients, According to Spherix Global Insights - Vimarsana News

U.S. Nephrologists Report Mixed Reactions to the Approval of GSK's Jesduvroq® (daprodustat) for the Treatment of Anemia in Dialysis Patients, According to Spherix Global Insights

/PRNewswire/ -- Since 2017, Spherix Global Insights has been monitoring the U.S. renal anemia market landscape, capturing nephrologists' perceptions and...

Aided by "Clean" FDA Label, US Dermatologists Report BMS' Sotyktu Has Potential to Delay Biologic Treatment in Plaque Psoriasis, According to Spherix Global Insights - Vimarsana News

Aided by "Clean" FDA Label, US Dermatologists Report BMS' Sotyktu Has Potential to Delay Biologic Treatment in Plaque Psoriasis, According to Spherix Global Insights

/PRNewswire/ -- On September 9, 2022, BMS announced the FDA approval of Sotyktu for moderate-to-severe plaque psoriasis (PsO), making it the first selective...

Eli Lilly's Olumiant is Filling a Critical Gap for Severe Alopecia Areata Patients, According to Spherix Global Insights - Vimarsana News

Eli Lilly's Olumiant is Filling a Critical Gap for Severe Alopecia Areata Patients, According to Spherix Global Insights

/PRNewswire/ -- On June 13, 2022, Eli Lilly announced the FDA approval of Olumiant for severe alopecia areata (AA), making it the first systemic therapy...

Eli Lilly's Olumiant is Filling a Critical Gap for Severe Alopecia Areata Patients, According to Spherix Global Insights - Vimarsana News

Eli Lilly's Olumiant is Filling a Critical Gap for Severe Alopecia Areata Patients, According to Spherix Global Insights

/PRNewswire/ -- On June 13, 2022, Eli Lilly announced the FDA approval of Olumiant for severe alopecia areata (AA), making it the first systemic therapy...

Spherix Global Insights Releases the Titles of Four Abstracts to be Presented at American Society of Nephrology (ASN) Kidney Week 2022 - Vimarsana News

Spherix Global Insights Releases the Titles of Four Abstracts to be Presented at American Society of Nephrology (ASN) Kidney Week 2022

/PRNewswire/ -- Spherix Global Insights, a leading market intelligence firm specializing in nephrology, is excited to announce the titles of four abstracts...